Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Cytokeratin 13 anticorps

Cet anticorps Souris Monoclonal détecte spécifiquement Cytokeratin 13 dans IF, FACS et IHC (f). Il présente une réactivité envers Humain.
N° du produit ABIN6937655

Aperçu rapide pour Cytokeratin 13 anticorps (ABIN6937655)

Antigène

Voir toutes Cytokeratin 13 (KRT13) Anticorps
Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))

Reactivité

  • 90
  • 37
  • 31
  • 11
  • 6
  • 5
  • 4
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain

Hôte

  • 63
  • 30
  • 1
  • 1
Souris

Clonalité

  • 56
  • 39
Monoclonal

Conjugué

  • 52
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp Cytokeratin 13 est non-conjugé

Application

  • 59
  • 43
  • 17
  • 16
  • 16
  • 15
  • 13
  • 11
  • 10
  • 9
  • 7
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

KRT13-2213
  • Specificité

    Cytokeratin 13 (KRT13) is the major acidic keratin, which together with KRT4, its basic partner, is expressed in the suprabasal layers of non-cornified stratified epithelia including tongue mucosa, esophagus, anal canal epithelium, tracheal epithelium, uterine cervix, and urothelium. Defects in the KRT13 gene are a cause of white sponge nevus of cannon (WSN), a rare autosomal dominant disorder, which predominantly affects non-cornified stratified squamous epithelia and is characterized by the presence of soft, white and spongy plaques in the oral mucosa. KRT13 has been used as a marker for non-keratinized squamous epithelium. It is also expressed in various squamous metaplasia, but it is down regulated in squamous dysplasia and squamous carcinoma.

    Réactivité croisée (Details)

    Human.

    Purification

    1.0mg/ml of Ab purified from Bioreactor by Protein A/G.

    Immunogène

    Recombinant full-length human KRT13 protein

    Isotype

    IgG
  • Indications d'application

    Known_Application: Immunofluorescence (1-2 μg/mL), Flow Cytometry (1-2 μg per million cells), Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 min at RT)(Staining of formalin-fixed tissues requires heating tissue sections in 10 mM Tris with 1 mM EDTA, pH 9.0, for 45 min at 95°C followed by cooling at RT for 20 minutes), Optimal dilution for a specific application should be determined.

    Positive_Control: HeLa or A431 cells. Skin or squamous cell carcinoma.

    Restrictions

    For Research Use only
  • Concentration

    1.0 mg/mL

    Buffer

    Prepared in 10 mM PBS, WITHOUT BSA and Azide.

    Agent conservateur

    Azide free

    Stock

    -20 °C,-80 °C

    Stockage commentaire

    Antibody without azide store at -20 to -80 °C. Antibody is stable for 24 months. Non-hazardous.

    Date de péremption

    24 months
  • Antigène

    Cytokeratin 13 (KRT13) (Keratin 13 (KRT13))

    Autre désignation

    KRT13

    Sujet

    CK13, Cytokeratin-13, Keratin Type I Cytoskeletal 13, Keratin-13, KRT13, Type I Cytoskeletal 13, WSN2,Cytokeratin 13 (Non-Keratinized Squamous Epithelial Marker)
    Cellular localisation: Cytoplasmic

    Poids moléculaire

    52kDa

    ID gène

    3860, 654550

    UniProt

    P13646
Vous êtes ici:
Chat with us!